Business Description
Inovio Pharmaceuticals is a biotechnology company based in Plymouth Meeting, Pennsylvania, focused on developing DNA-based medicines to treat and prevent diseases linked to HPV, cancer, and infectious conditions. The company uses its proprietary platform to design and deliver these treatments, with several candidates currently in clinical trials targeting conditions such as recurrent respiratory papillomatosis, cervical disease, glioblastoma, Ebola, COVID-19, and HIV. Inovio works alongside a broad network of partners, including AstraZeneca, Regeneron Pharmaceuticals, the National Institutes of Health, and several academic institutions.
